【24h】

TYLOSIN

机译:泰洛斯

获取原文

摘要

Tylosin is a macrolide antibiotic produced by fermentation from a strain of the soil microorganism, Streptomyces fradiae. The compound is active against Gram-positive bacteria, mycoplasma and certain Gram-negative bacteria. Like other macrolide antibiotics, tylosin inhibits protein synthesis by inhibiting aminoacyl-transfer ribonucleic acid (tRNA) and peptidyl-tRNA binding to the ribosomes. Tylosin consists of one major factor, tylosin A. Three minor factors— desmycosin (tylosin B), macrocin (tylosin C) and relomycin (tylosin D)—may also be present in varying amounts, depending upon the manufacturing source (Figure 1). Most of the microbiological activity resides with tylosin A. Tylosin B, C and D and dihydrodesmycosin (a metabolite) have approximately 83%, 75%, 35% and 31% of the activity of tylosin A, respectively.
机译:Tylosin是一种通过来自土壤微生物菌株的发酵产生的大环内酯抗生素,Streptomyces Fradiae。该化合物对抗革兰氏阳性细菌,支原体和某些革兰氏阴性细菌。与其他大环内酯抗生素一样,替斯汀通过抑制氨基酰转移核糖核酸(TRNA)和肽基-TRNA与核糖体结合而抑制蛋白质合成。 Tylosin由一种主要因素组成,Tylosin A.三个次要因素(Tylosin B),宏键(Tylosin C)和Relomycin(Tylosin D)-May也以不同的量存在,这取决于制造源(图1)。大多数微生物活性都存在于Tylosin A. Tylosin B,C和D和二氢霉素(代谢物)分别具有约83%,75%,35%和31%的Tylosin A活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号